Abstract:We recently identified the Phafin protein family, whose members all contain an N-terminal PH domain (pleckstrin homology) and a C-terminal FYVE (Fab1, YGLO23, Vps27, and EEA1) domain. LAPF (lysosome-associated apoptosis-inducing protein containing PH and FYVE domains, also known as Phafin-1), as one representative member of this new family, has been shown to be able to initiate caspase-independent apoptosis through lysosomal-mitochondrial apoptotic pathway. Here, we describe the cloning and functional characterization of another Phafin member, EAPF (endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains)/Phafin-2. Overexpression of EAPF/Phafin-2 enhances the sensitivity of L929 and MCF-7 cells to TNF-α-induced apoptosis, concomitant with its partial translocation to endoplasmic reticulum (ER). Both the PH and the FYVE domains contribute to the ER translocation of EAPF/Phafin-2 as well as EAPF/Phafin-2-enhanced apoptosis. Knockdown of mouse and human EAPF/Phafin-2 expression protects L929 cells and MCF-7 cells from TNF-α-induced apoptosis, respectively. We demonstrate that EAPF/Phafin-2 induces a much sharper and more rapid Ca2+ influx triggered by TNF-α and Ca2+ release ER contributes to the enhancement of EAPF/Phafin-2 in TNF-induced apoptosis. EAPF/Phafin-2 increases the activity of caspase 12, suggesting that EAPF/Phafin-2 is involved in ER-related apoptotic pathway. Overexpression of EAPF/Phafin-2 also enhances TNF-α-induced activity of caspase 3 (but not caspase 8 or 9), and promotes TNF-α-triggered mitochondrial membrane permeabilization (MMP) in L929 cells, including dissipation of mitochondrial membrane potential and release of AIF. Besides, EAPF/Phafin-2 also suppresses the unfolded protein response by inhibiting phosphorylation of eIF2α. Therefore, our results demonstrate that EAPF/Phafin-2 facilitates TNF-α-induced cellular apoptosis through an ER-mitochondrial apoptotic pathway, which may improve our understanding of drug-induced cancer cell death and cancer chemotherapy.

Interaction Between Plasminogen Activator Inhibitor Type-2 and Pre-Mrna Processing Factor 8.

Interaction of Plasminogen Activator Inhibitor-2 and Proteasome Subunit, Beta Type 1

EAPF/Phafin-2, a Novel Endoplasmic Reticulum-Associated Protein, Facilitates TNF-α-triggered Cellular Apoptosis Through Endoplasmic Reticulum-Mitochondrial Apoptotic Pathway

Expression of Human Plasminogen Activator Inhibitor-2 in the Baculovirus Expression System.

Prp Octarepeats Region Determined the Interaction with Caveolin-1 and Phosphorylation of Caveolin-1 and Fyn

Biological Function of Fusion Protein ATF-PAI2CD

Protection of Two PAI-2 Mutants Against TNF-α-Mediated Apoptosis

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.

Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition

Polymerization of Plasminogen Activator Inhibitor-1.

Yeast Two-Hybrid Screening of Proteins Interacting with Plasmin Receptor Subunit: C-terminal Fragment of Annexin A2.

Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model

Renaturation, Purification, and Characterization of Human Plasminogen Activator Inhibitor Type 2 (Pai-2) Accumulated at High Level in Escherichia Coli

The Structure Basis of the Poor Fibrin Specificity of Urokinase (Ii)--the Inhibition of Urokinase A Chain 149-157 on the Fibrin Stimulated Activation of Plasminogen by Tissue Type Plasminogen Activator.

Plasminogen Activator Inhibitor-1 in Cancer Research.

High-Level Expression of Active Human Plasminogen Activator Inhibitor Type 1 (Pai-1) in E-Coli

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo

Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation